Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 10—October 2024
Research

Virulence of Burkholderia pseudomallei ATS2021 Unintentionally Imported to United States in Aromatherapy Spray

Christopher K. CoteComments to Author , Kevin D. Mlynek, Christopher P. Klimko, Sergei S. Biryukov, Sherry Mou, Melissa Hunter, Nathaniel O. Rill, Jennifer L. Dankmeyer, Jeremey A. Miller, Yuli Talyansky, Michael L. Davies, J. Matthew Meinig, Stephanie A. Halasohoris, Anette M. Gray, Jade L. Spencer, Ashley L. Babyak, M. Kelly Hourihan, Bobby J. Curry, Ronald G. Toothman, Sara I. Ruiz, Xiankun Zeng, Keersten M. Ricks, Tamara L. Clements, Christina E. Douglas, Suma Ravulapalli, Christopher P. Stefan, Charles J. Shoemaker, Mindy G. Elrod, Jay E. Gee, Zachary P. Weiner, Ju Qiu, Joel A. Bozue, Nancy A. Twenhafel, and David DeShazerComments to Author 
Author affiliations: United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA (C.K. Cote, K.D. Mlynek, C.P. Klimko, S.S. Biryukov, S. Mou, M. Hunter, N.O. Rill, J.L. Dankmeyer, J.A. Miller, Y. Talyansky, M.L. Davies, J.M. Meinig, S.A. Halasohoris, A.M. Gray, J.L. Spencer, A.L. Babyak, M.K. Hourihan, B.J. Curry, R.G. Toothman, S.I. Ruiz, X. Zeng, K.M. Ricks, T.L. Clements, C.E. Douglas, S. Ravulapalli, C.P. Stefan, C.J. Shoemaker, J. Qiu, J.A. Bozue, N.A. Twenhafel, D. DeShazer); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M.G. Elrod, J.E. Gee, Z.P. Weiner)

Main Article

Table

Median lethal dose of aerosolized Burkholderia mallei ATS2021 in C57BL/6 and BALB/c mice*

Mice† Day Inhaled dose LD50 (95% CI) TTD median (95% CI) TTD mean (SE)
C57BL/6
 21 9.90 × 10–1 56.4 CFU (21.3–150.2) >21 >21
1.32 ×101 >21 16.5 (0.7)
1.07 ×102 18.0 (11.0–UD) 15.9 (0.9)
1.15 ×103 4.0 (3.0–5.0) 4.4 (0.3)
4.49 ×103 3.0 (UD) 3.1 (0.1)
60
 9.9 × 10–1 5.8 CFU (2.0–15.1)
 >60 51.0 (.)
1.32 ×101 41.5 (12.0–UD) 39.3 (5.6)
1.07 ×102 18.0 (11.0–26.0) 20.9 (3.2)
1.15 ×103 4.0 (3.0–5.0) 4.4 (0.3)
4.49 ×103
 3.0 (UD)
 3.1 (0.1)
BALB/c 21 4.00 × 10–1 4.1 CFU (1.8–11.3) >21 4.0 (.)
2 >21 4.9 (0.1)
2.05 ×101 4.0 (3.0 –4.0) 4.3 (0.3)
1.86 ×102 3.0 (UD) 3.1 (0.1)
9.60 ×102 3.0 (2.0–3.0) 2.9 (0.1)
60 4.00 × 10–1 4.1 CFU (1.8–11.3) >60 4.0 (.)
2 >60 4.9 (0.1)
2.05 ×101 4.0 (3.0–4.0) 4.3 (0.3)
1.86E ×102 3.0 (UD) 3.1 (0.1)
9.60 ×102 3.0 (2.0–3.0) 2.9 (0.1)

*LD50, 50% lethal dose; TTD, time to death or euthanasia in accordance with early intervention criter†ia; UD, undetermined. †Female; 7–9 weeks of age at time of exposure to aerosolized bacteria.

Main Article

Page created: September 11, 2024
Page updated: September 11, 2024
Page reviewed: September 11, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external